273 related articles for article (PubMed ID: 11053416)
1. Camel single-domain antibodies as modular building units in bispecific and bivalent antibody constructs.
Els Conrath K; Lauwereys M; Wyns L; Muyldermans S
J Biol Chem; 2001 Mar; 276(10):7346-50. PubMed ID: 11053416
[TBL] [Abstract][Full Text] [Related]
2. Generation of single domain antibody fragments derived from camelids and generation of manifold constructs.
Vincke C; Gutiérrez C; Wernery U; Devoogdt N; Hassanzadeh-Ghassabeh G; Muyldermans S
Methods Mol Biol; 2012; 907():145-76. PubMed ID: 22907350
[TBL] [Abstract][Full Text] [Related]
3. Single variable domain-IgG fusion. A novel recombinant approach to Fc domain-containing bispecific antibodies.
Shen J; Vil MD; Jimenez X; Iacolina M; Zhang H; Zhu Z
J Biol Chem; 2006 Apr; 281(16):10706-14. PubMed ID: 16481314
[TBL] [Abstract][Full Text] [Related]
4. Single domain camel antibodies: current status.
Muyldermans S
J Biotechnol; 2001 Jun; 74(4):277-302. PubMed ID: 11526908
[TBL] [Abstract][Full Text] [Related]
5. Selection and identification of single domain antibody fragments from camel heavy-chain antibodies.
Arbabi Ghahroudi M; Desmyter A; Wyns L; Hamers R; Muyldermans S
FEBS Lett; 1997 Sep; 414(3):521-6. PubMed ID: 9323027
[TBL] [Abstract][Full Text] [Related]
6. Construction, expression, and activity of a bivalent bispecific single-chain antibody.
Mallender WD; Voss EW
J Biol Chem; 1994 Jan; 269(1):199-206. PubMed ID: 8276795
[TBL] [Abstract][Full Text] [Related]
7. Recombinant single-chain Fv fragments carrying C-terminal cysteine residues: production of bivalent and biotinylated miniantibodies.
Kipriyanov SM; Dübel S; Breitling F; Kontermann RE; Little M
Mol Immunol; 1994 Oct; 31(14):1047-58. PubMed ID: 7935496
[TBL] [Abstract][Full Text] [Related]
8. Generation of dual-variable-domain immunoglobulin molecules for dual-specific targeting.
Gu J; Ghayur T
Methods Enzymol; 2012; 502():25-41. PubMed ID: 22208980
[TBL] [Abstract][Full Text] [Related]
9. The assembly of single domain antibodies into bispecific decavalent molecules.
Stone E; Hirama T; Tanha J; Tong-Sevinc H; Li S; MacKenzie CR; Zhang J
J Immunol Methods; 2007 Jan; 318(1-2):88-94. PubMed ID: 17141798
[TBL] [Abstract][Full Text] [Related]
10. Nanobody production can be simplified by direct secretion from Escherichia coli.
Iwaki T; Hara K; Umemura K
Protein Expr Purif; 2020 Jun; 170():105607. PubMed ID: 32062022
[TBL] [Abstract][Full Text] [Related]
11. Expression and purification of monospecific and bispecific recombinant antibody fragments derived from antibodies that block the CD80/CD86-CD28 costimulatory pathway.
Dincq S; Bosman F; Buyse MA; Degrieck R; Celis L; de Boer M; Van Doorsselaere V; Sablon E
Protein Expr Purif; 2001 Jun; 22(1):11-24. PubMed ID: 11388794
[TBL] [Abstract][Full Text] [Related]
12. Expression of a bispecific dsFv-dsFv' antibody fragment in Escherichia coli.
Schmiedl A; Breitling F; Dübel S
Protein Eng; 2000 Oct; 13(10):725-34. PubMed ID: 11112512
[TBL] [Abstract][Full Text] [Related]
13. The first constant domain (C(H)1 and C(L)) of an antibody used as heterodimerization domain for bispecific miniantibodies.
Müller KM; Arndt KM; Strittmatter W; Plückthun A
FEBS Lett; 1998 Jan; 422(2):259-64. PubMed ID: 9490020
[TBL] [Abstract][Full Text] [Related]
14. Generation of a functional monomolecular protein lattice consisting of an s-layer fusion protein comprising the variable domain of a camel heavy chain antibody.
Pleschberger M; Neubauer A; Egelseer EM; Weigert S; Lindner B; Sleytr UB; Muyldermans S; Sára M
Bioconjug Chem; 2003; 14(2):440-8. PubMed ID: 12643755
[TBL] [Abstract][Full Text] [Related]
15. [Construction and characterization of bispecific single-chain antibody fragments SZ-2/SZ-21 against platelet glycoprotein Ib alpha and beta3].
Dai K; An G; Ruan C
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1493-7. PubMed ID: 12509914
[TBL] [Abstract][Full Text] [Related]
16. Bivalent antibody phage display mimics natural immunoglobulin.
Lee CV; Sidhu SS; Fuh G
J Immunol Methods; 2004 Jan; 284(1-2):119-32. PubMed ID: 14736422
[TBL] [Abstract][Full Text] [Related]
17. Effect of domain order on the activity of bacterially produced bispecific single-chain Fv antibodies.
Kipriyanov SM; Moldenhauer G; Braunagel M; Reusch U; Cochlovius B; Le Gall F; Kouprianova OA; Von der Lieth CW; Little M
J Mol Biol; 2003 Jun; 330(1):99-111. PubMed ID: 12818205
[TBL] [Abstract][Full Text] [Related]
18. The effect of variable domain orientation and arrangement on the antigen-binding activity of a recombinant human bispecific diabody.
Lu D; Jimenez X; Witte L; Zhu Z
Biochem Biophys Res Commun; 2004 May; 318(2):507-13. PubMed ID: 15120630
[TBL] [Abstract][Full Text] [Related]
19. Studies of thermostability in Camelus bactrianus (Bactrian camel) single-domain antibody specific for the mutant epidermal-growth-factor receptor expressed by Pichia.
Omidfar K; Rasaee MJ; Kashanian S; Paknejad M; Bathaie Z
Biotechnol Appl Biochem; 2007 Jan; 46(Pt 1):41-9. PubMed ID: 16848761
[TBL] [Abstract][Full Text] [Related]
20. Production and characterization of a new antibody specific for the mutant EGF receptor, EGFRvIII, in Camelus bactrianus.
Omidfar K; Rasaee MJ; Modjtahedi H; Forouzandeh M; Taghikhani M; Bakhtiari A; Paknejad M; Kashanian S
Tumour Biol; 2004; 25(4):179-87. PubMed ID: 15557755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
